Pfizer (PFE) Starts EU Submission of Variant-Adapted Vaccine

Pfizer PFE and its partner BioNTech BNTX announced that the European Medicines Agency (EMA) initiated the rolling review of their regulatory application for a variant-adapted version of the companies’ COVID-19 vaccine.